Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 31 matching records.
31 results — page 1 of 2
- Level DLaboratory StudyEurope PMC
Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats
Laboratory Study on Scar, Chronic Inflammation, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level DNarrative ReviewEurope PMC
A bibliometric analysis of research trends in mesenchymal stem cell therapy for neonatal bronchopulmonary dysplasia: 2004-2024
Narrative Review on Chronic Inflammation, Immune Modulation, published in Front Pediatr (2025) — summary generated from the PubMed abstract.
- 2025
Front Pediatr1 citations - Level DAnimal StudyPubMed
Combinational Therapy of Mesenchymal Stem Cells and Metformin in Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rat Model.
Animal Study on Chronic Inflammation, published in Appl Biochem Biotechnol (2025) — summary generated from the PubMed abstract.
- 2025
Appl Biochem Biotechnol - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell therapy for pulmonary hypertension: an update
Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.
- 2025
Front Bioeng Biotechnol - Level CProspective StudyPubMed
Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up.
Prospective Study on Immune Modulation, published in Cytotherapy (2024) — summary generated from the PubMed abstract.
- 2024
Cytotherapy - Level DNarrative ReviewEurope PMC
Novel insights into the potential applications of stem cells in pulmonary hypertension therapy
Narrative Review, published in Respir Res (2024) — summary generated from the PubMed abstract.
- 2024
Respir Res2 citations - Level ASystematic ReviewPubMed
The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review.
Systematic Review on Scar, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus1 citations - Level DNarrative ReviewEurope PMC
Impact of extracellular vesicles on the pathogenesis, diagnosis, and potential therapy in cardiopulmonary disease
Narrative Review on Systemic / IV, published in Front Pharmacol (2023) — summary generated from the PubMed abstract.
- 2023
Front Pharmacol3 citations - Level DAnimal StudyPubMed
Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
Animal Study, published in Sci Rep (2023) — summary generated from the PubMed abstract.
- 2023
Sci Rep31 citations - Level CProspective StudyPubMed
Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.
Prospective Study on Scar, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther - Level BClinical TrialEurope PMC
Stem cell therapy for pulmonary arterial hypertension: An update
Clinical Trial, published in J Heart Lung Transplant (2022) — summary generated from the PubMed abstract.
- 2022
J Heart Lung Transplant20 citations - Level DNarrative ReviewEurope PMC
Stem cell-based therapy for pulmonary fibrosis
Narrative Review, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther42 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies
Narrative Review on Chronic Inflammation, published in J Interv Cardiol (2022) — summary generated from the PubMed abstract.
- 2022
J Interv Cardiol11 citations - Level DAnimal StudyPubMed
Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension.
Animal Study on Chronic Inflammation, published in Sci Rep (2021) — summary generated from the PubMed abstract.
- 2021
Sci Rep - Level DNarrative ReviewEurope PMC
Stem cell therapy for chronic obstructive pulmonary disease
Narrative Review, published in Chin Med J (Engl) (2021) — summary generated from the PubMed abstract.
- 2021
Chin Med J (Engl)22 citations - Level AMeta-analysisEurope PMC
Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies
Meta-analysis, published in Stem Cell Res Ther (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cell Res Ther37 citations - Level DAnimal StudyEurope PMC
Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
Animal Study on Systemic / IV, published in Mol Ther Oncolytics (2020) — summary generated from the PubMed abstract.
- 2020
Mol Ther Oncolytics31 citations - Level DNarrative ReviewEurope PMC
Cell-based therapy for idiopathic pulmonary fibrosis
Narrative Review, published in Stem Cell Investig (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Investig27 citations - Level BClinical TrialEurope PMC
Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?
Clinical Trial on Cardiovascular Disease, published in Pulm Circ (2018) — summary generated from the PubMed abstract.
- 2018
Pulm Circ15 citations - Level CProspective StudyEurope PMC
Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis: Improvement with Target Combination
Prospective Study, published in Cell Transplant (2018) — summary generated from the PubMed abstract.
- 2018
Cell Transplant36 citations - Level DNarrative ReviewEurope PMC
Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?
Narrative Review, published in Am J Stem Cells (2018) — summary generated from the PubMed abstract.
- 2018
Am J Stem Cells17 citations - Level DAnimal StudyPubMed
Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
Animal Study with a reported sample of 7 on Systemic / IV, published in Stem Cell Res Ther (2017) — summary generated from the PubMed abstract.
- 2017
- n = 7
Stem Cell Res Ther - Level BClinical TrialPubMed
Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.
Clinical Trial on Systemic / IV, published in Stem Cell Rev Rep (2015) — summary generated from the PubMed abstract.
- 2015
Stem Cell Rev Rep - Level DNarrative ReviewEurope PMC
Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series)
Narrative Review on Chronic Inflammation, published in Pulm Circ (2015) — summary generated from the PubMed abstract.
- 2015
Pulm Circ8 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406